4//SEC Filing
Cogley Brian 4
Accession 0001683168-25-001395
CIK 0001759186other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:29 PM ET
Size
6.0 KB
Accession
0001683168-25-001395
Insider Transaction Report
Form 4
Cogley Brian
Chief Financial Officer
Transactions
- Award
Non-Qualified Stock Options (right to buy)
2025-03-04+10,000→ 22,500 totalExercise: $10.56→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]On March 4, 2025, the reporting person received a grant of 10,000 non-qualified stock options, under the 2022 equity incentive plan.
- [F2]The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.
- [F3]Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28.
- [F4]Expiration date is ten years from the day of grant.
Documents
Issuer
Coeptis Therapeutics Holdings, Inc.
CIK 0001759186
Entity typeother
Related Parties
1- filerCIK 0002008384
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:29 PM ET
- Size
- 6.0 KB